In the present study, seven potential breast cancer marker candidates (SFRP1, SFRP2, SFRP5, WIF1, DKK3, ITIH5, and RASSF1A) were studied with regard to early breast cancer detection in serum. This evidence concerns the gene SFRP2 and breast carcinoma.